Skip to main content
. 2017 Jul 1;144:330–339. doi: 10.1016/j.antiviral.2017.06.021

Table 4.

Evaluation of compound 312 analogs. IC50 determined by FBA on SARS-CoV nsp14 and RNMT MTase activities using GpppAC4 substrate.

Compounds Structure IC50 (μM) on
SARS nsp14 RNMT
312 Image 2 7.3 ± 0.4 14.3 ± 1
457 Image 3 6.2 ± 0.4 8.8 ± 0.6
278 Image 4 9.1 ± 0.7 16.8 ± 2
1264 Image 5 13.5 ± 2 13.7 ± 0.8
133 Image 6 No inhibition 365.2 ± 186
510 Image 7 No inhibition 159 ± 36
706 Image 8 No inhibition 226.8 ± 29
503 Image 9 No inhibition 102.2 ± 21